Regulation of sphingomyelin phosphodiesterase acid-like 3A gene (SMPDL3A) by liver X receptors

Molecular Pharmacology

Volumn 82, Issue 4, 2012, Pages 719-727

  Noto, Paul B ^a,b   Bukhtiyarov, Yuri ^a   Shi, Meng ^a   McKeever, Brian M ^a   McGeehan, Gerard M ^a   Lala, Deepak S ^a  

^a Vitae Pharmaceuticals Inc   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; LIVER X RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE ACID LIKE 3A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INDUCTION; GENE TARGETING; GENETIC SCREENING; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; BENZOATES; BENZYLAMINES; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NICOTINIC ACIDS; ORPHAN NUCLEAR RECEPTORS; RESPONSE ELEMENTS; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; SPHINGOMYELIN PHOSPHODIESTERASE; TETRAHYDRONAPHTHALENES;

EID: 84866884070     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.078865     Document Type: Article

References (29)

1. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
2. Bardot O, Aldridge TC, Latruffe N, and Green S (1993) PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun 192:37-45. (Pubitemid 23205265)
3. Boehm MF, Zhang L, Zhi L, McClurg MR, Berger E, Wagoner M, Mais DE, Suto CM, Davies JA, and Heyman RA (1995) Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 38:3146-3155.
4. Bookout AL and Mangelsdorf DJ (2003) Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 1:e012.
5. Calkin AC and Tontonoz P (2010) Liver X receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 30:1513-1518.
6. Chang KC, Shen Q, Oh IG, Jelinsky SA, Jenkins SF, Wang W, Wang Y, LaCava M, Yudt MR, Thompson CC, Freedman LP, Chung JH, and Nagpal S. (2008) Liver X receptor is a therapeutic target for photoaging and chronological skin aging. Mol Endocrinol 22:2407-2419.
7. Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, et al. (2002) Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 45:1963-1966. (Pubitemid 34477709)
8. Fontaine C, Rigamonti E, Nohara A, Gervois P, Teissier E, Fruchart JC, Staels B, and Chinetti-Gbaguidi G (2007) Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ Res 101:40-49. (Pubitemid 47094622)
9. Gearing KL, Göttlicher M, Teboul M, Widmark E, and Gustafsson JA (1993) Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci USA 90:1440-1444. (Pubitemid 23058188)
10. Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM, Rosenfeld MG, and Glass CK (2007) Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ. Mol Cell 25:57-70. (Pubitemid 46049061)
11. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, and Kliewer SA (2003) Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-α. Mol Endocrinol 17:386-394. (Pubitemid 36315633)
12. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, and Mangelsdorf DJ (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc Natl Acad Sci USA 96:266-271. (Pubitemid 29036088)
13. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, and Tontonoz P (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213-219. (Pubitemid 36227724)
14. Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, and Tontonoz P (2001) LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA 98:507-512. (Pubitemid 32105072)
15. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, and Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956.
16. Li Y, Bolten C, Bhat BG, Woodring-Dietz J, Li S, Prayaga SK, Xia C, and Lala DS (2002) Induction of human liver X receptor α gene expression via an autoregulatory loop mechanism. Mol Endocrinol 16:506-514. (Pubitemid 34214570)
17. Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ, Tontonoz P, and Edwards PA (2002) Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors α and β. J Biol Chem 277:31900-31908. (Pubitemid 34968998)
18. Pehkonen P, Welter-Stahl L, Diwo J, Ryynänen J, Wienecke-Baldacchino A, Heikkinen S, Treuter E, Steffensen KR, and Carlberg C (2012) Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages. BMC Genomics 13: 50.
19. Phelan CA, Weaver JM, Steger DJ, Joshi S, Maslany JT, Collins JL, Zuercher WJ, Willson TM, Walker M, Jaye M, et al. (2008) Selective partial agonism of liver X receptor α is related to differential corepressor recruitment. Mol Endocrinol 22:2241-2249.
20. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, and Mangelsdorf DJ (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev 14:2819-2830.
21. Sandelin A and Wasserman WW (2005) Prediction of nuclear hormone receptor response elements. Mol Endocrinol 19:595-606. (Pubitemid 40349434)
22. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, et al. (2000) Role of LXRs in control of lipogenesis. Genes Dev 14:2831-2838.
23. Shang Y and Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468. (Pubitemid 34270263)
24. Suon S, Zhao J, Villarreal SA, Anumula N, Liu M, Carangia LM, Renger JJ, and Zerbinatti CV (2010) Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats. Mol Neurodegener 5:44.
25. Truman JP, Al Gadban MM, Smith KJ, and Hammad SM (2011) Acid sphingomyelinase in macrophage biology. Cell Mol Life Sci 68:3293-3305.
26. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, and Tontonoz P (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc Natl Acad Sci USA 97:12097-12102.
27. Wang SW, Parhar K, Chiu KJ, Tran A, Gangoiti P, Kong J, Gonzalez M, Salh B, Duronio V, Steinbrecher UP, et al. (2007) Pertussis toxin promotes macrophage survival through inhibition of acid sphingomyelinase and activation of the phosphoinositide 3-kinase/protein kinase B pathway. Cell Signal 19:1772-1783. (Pubitemid 46935433)
28. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, and Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033-1045.
29. Wright KO, Messing EM, and Reeder JE (2002) Increased expression of the acid sphingomyelinase-like protein ASML3a in bladder tumors. J Urol 168:2645-2649. (Pubitemid 35402709)